Literature DB >> 2525437

T lymphocyte subset abnormalities and HLA antigens in scleroderma (systemic sclerosis).

A J Barnett1, B D Tait, M A Barnett, B H Toh.   

Abstract

Studies of T lymphocyte subsets were carried out in a group of 50 scleroderma patients, of whom 46 were also HLA phenotyped. The total lymphocyte count was depressed in 22 patients, and CD4 (helper cells) numbers were normal. CD8 (suppressor-cytotoxic) cells were reduced in 27 patients, and the CD4/CD8 number ratio increased above normal in three additional patients, resulting in 30 patients being classified as CD8-deficient. In the 46 patients HLA phenotyped, DRw8 was significantly increased in the entire patient group, but when the patients were subdivided into CD8-deficient (n = 29) and CD8-normal (n = 17), the increase in DRw8 was confined to the CD8-deficient patients. B18 was also increased in patients with limited sclerosis, while DR4 and DRw53 were significantly decreased and DR5 significantly increased in patients with more extensive skin sclerosis. These findings suggest that scleroderma is a heterogeneous condition and that this heterogeneity is reflected in different HLA profiles in patients subtyped according to their clinical profile and subpopulations of T cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2525437      PMCID: PMC1541735     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  28 in total

1.  MICRODROPLET ASSAY OF HUMAN SERUM CYTOTOXINS.

Authors:  P I TERASAKI; J D MCCLELLAND
Journal:  Nature       Date:  1964-12-05       Impact factor: 49.962

2.  [Research of an association between HL-A antigens and systemic scleroderma].

Authors:  J Crouzet; M C Marbach; J P Camus; P Godeau; G Herreman; D Richier; J Hors; J Dausset
Journal:  Nouv Presse Med       Date:  1975-10-18

3.  A molecular basis for MHC class II--associated autoimmunity.

Authors:  J A Todd; H Acha-Orbea; J I Bell; N Chao; Z Fronek; C O Jacob; M McDermott; A A Sinha; L Timmerman; L Steinman
Journal:  Science       Date:  1988-05-20       Impact factor: 47.728

4.  Isolation of B and T lymphocytes by nylon fiber columns.

Authors:  C Werner; P T Klouda; M C Corréa; P Vassalli; M Jeannet
Journal:  Tissue Antigens       Date:  1977-04

5.  Isolation of leucocytes from human blood. Further observations. Methylcellulose, dextran, and ficoll as erythrocyteaggregating agents.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

6.  The association of HLA-B8 with visceral disease in systemic sclerosis.

Authors:  P Hughes; K Gelsthorpe; R W Doughty; N R Rowell; F D Rosenthal; I B Sneddon
Journal:  Clin Exp Immunol       Date:  1978-03       Impact factor: 4.330

7.  Analysis of cell populations with a fluorescence-activated cell sorter.

Authors:  M R Loken; L A Herzenber
Journal:  Ann N Y Acad Sci       Date:  1975-06-30       Impact factor: 5.691

8.  Identification and characterization of mitochondria autoantigens in progressive systemic sclerosis: identity with the 72,000 dalton autoantigen in primary biliary cirrhosis.

Authors:  F Alderuccio; B H Toh; A J Barnett; J S Pedersen
Journal:  J Immunol       Date:  1986-09-15       Impact factor: 5.422

9.  Systemic sclerosis (scleroderma): clinical, genetic, and serologic subsets.

Authors:  J Z Livingston; T E Scott; F M Wigley; G J Anhalt; W B Bias; R H McLean; M C Hochberg
Journal:  J Rheumatol       Date:  1987-06       Impact factor: 4.666

10.  Histocompatibility antigens in progressive systemic sclerosis (scleroderma).

Authors:  N S Birnbaum; G P Rodnan; B S Rabin; S Bassion
Journal:  J Rheumatol       Date:  1977       Impact factor: 4.666

View more
  8 in total

1.  Increased CD8+ T cell apoptosis in scleroderma is associated with low levels of NF-kappa B.

Authors:  Aharon Kessel; Itzhak Rosner; Michael Rozenbaum; Devy Zisman; Anca Sagiv; Zehava Shmuel; Edmond Sabo; Elias Toubi
Journal:  J Clin Immunol       Date:  2004-01       Impact factor: 8.317

Review 2.  Epidemiology of scleroderma.

Authors:  A J Silman
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

Review 3.  Major histocompatibility complex class II genes and systemic sclerosis.

Authors:  D Briggs; K I Welsh
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

4.  CD4+ and CD8+ subsets: naive and memory cells in the peripheral blood of patients with systemic sclerosis.

Authors:  R Gorla; P Airò; A Malagoli; G Carella; E Prati; D Brugnoni; F Franceschini; R Cattaneo
Journal:  Clin Rheumatol       Date:  1994-03       Impact factor: 2.980

5.  Antinuclear antibodies in patients with scleroderma (systemic sclerosis) and in their blood relatives and spouses.

Authors:  A J Barnett; L J McNeilage
Journal:  Ann Rheum Dis       Date:  1993-05       Impact factor: 19.103

Review 6.  Challenges and opportunities in treating inflammation associated with pulmonary hypertension.

Authors:  Norbert F Voelkel; Rasa Tamosiuniene; Mark R Nicolls
Journal:  Expert Rev Cardiovasc Ther       Date:  2016-05-04

7.  An immunogenetic analysis of the T-cell recognition of the major house dust mite allergen Der p 2: identification of high- and low-responder HLA-DQ alleles and localization of T-cell epitopes.

Authors:  R M O'Brien; W R Thomas; I Nicholson; J R Lamb; B D Tait
Journal:  Immunology       Date:  1995-10       Impact factor: 7.397

8.  Response of T-cell subpopulations to superantigen and recall antigen stimulation in systemic sclerosis.

Authors:  Sajad Ahmad Dar; Sambit Nath Bhattacharya; Shukla Das; Vishnampettai Ganapathysubramanian Ramachandran; Basu Dev Banerjee; Prateek Arora
Journal:  Indian J Dermatol       Date:  2012-05       Impact factor: 1.494

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.